Deniz Can Guven
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Deniz Can Guven
Jun 28, 2024, 08:19 |
Societies
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 26, 2024, 14:33 |
Blog
NOM after IO in early-stage MSI-H GI cancers
Deniz Can Guven, The Editorial Board Member in BMC Cancer, shared on X: "Out in Cancer…
Jun 26, 2024, 08:29 |
Blog
Deniz Can Guven: Excited to see younger brother grow with the mentorship of Yuksel Urun
Deniz Can Guven, Editorial Board Member of BMC Cancer, shared a post by Enes Erul,…
Jun 24, 2024, 03:22 |
Insight
Deniz Can Guven: The OS benefits of cancer drugs approved by surrogate endpoints
Deniz Can Guven, The Editorial Board Member in BMC Cancer, shared on X: "Out in…
Jun 10, 2024, 06:13 |
Blog
Deniz Can Guven: Come and join us at ESMOGI24
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, shared on X: "Less…
May 18, 2024, 06:04 |
Blog
Deniz Can Guven: The 1st-in-human phase 1 study on arginase inhibitor INCB001158
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, shared on X/Twitter:…
May 13, 2024, 15:05 |
Blog
Taha Koray Sahin: Promising tool for real-world patient care
Taha Koray Sahin, Medical Oncologist at Hacettepe University, shared on X/Twitter: "I am thrilled to share…
Apr 9, 2024, 15:45 |
Insight
Review on the long-term effects of Immune Checkpoint Inhibitors - DKFZ German Cancer Research Center
Quoting DKFZ German Cancer Research Center on LinkedIn: "Review on the long-term effects of Immune…
Mar 16, 2024, 10:49 |
Blog
Deniz Can Guven: We reviewed the available evidence regarding ICI use in patients with frailty
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, recently shared on…
Feb 27, 2024, 15:37 |
Blog
Deniz Can Guven: Join us for another great ESMOYOC YO4YO Virtual Session with Angela Lamarca
Deniz Can Guven, Committee Member at ESMO - European Society for Medical Oncology, recently shared…
1
2
All:
12
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube